Veritas In Silico Inc.

Japanese biotechnology company specializing in AI-driven discovery of mRNA-targeted small molecule and nucleic acid drugs using its aibVIS platform. Engaged in joint research and patent filings with pharmaceutical partners for lncRNA-targeting therapies. Listed on Tokyo Stock Exchange Growth Market.

To provide comprehensive coverage, we aggregate data and news under the name Veritas In Silico, encompassing the following company names, divisions, and related entities:

VIS.

This list encompasses current and former names, alternate names, and key divisions associated with Veritas In Silico, ensuring you can easily find all relevant information under a single, unified profile.